title: Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
authors.affiliation: Harefield Hospital, Middlesex, England.
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: Packham
authors.forename: C
authors.initials: C
authors.lastname: Kingswood
authors.forename: H
authors.initials: H
authors.lastname: Cairns
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: D
authors.initials: D
authors.lastname: Thompson
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone